Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies
Source: BioSpace

Leap Therapeutics: Leap Therapeutics Reports Third Quarter 2020 Financial Results

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended September 30, 2020 . Leap Third Quarter Highlights: First patient dosed in Phase 2a study of Leap's anti-Dickkopf-1 (DKK1) antibo

Read full article »
Leap Therapeutics's Competitors | Leap Therapeutics's News | Leap Therapeutics's Financials

February 27, 2021

MarketScreener

Breaking Notice: Rosen, a Globally Recognized Law Firm, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUE

(marketscreener.com) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of th... See more »

February 28, 2021

Seeking Alpha

Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q4 2020 Results - Earnings Call Transcript

See more »

February 27, 2021

MarketScreener

Breaking Notice: Rosen, a Globally Recognized Law Firm, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUE

(marketscreener.com) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of th... See more »

February 28, 2021

Seeking Alpha

Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q4 2020 Results - Earnings Call Transcript

See more »
Stay up-to-date with the latest news on Leap Therapeutics

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Chris Mirabelli's photo - CEO of Leap Therapeutics

CEO

Chris Mirabelli

CEO Approval Rating

73/100

Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more

Stay up-to-date with the latest news on Leap Therapeutics